An anti-PMEL antibody-drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial. - Carlino MS; Kapiteijn E; Piperno-Neumann S; Sullivan RJ; Carvajal R; Dummer R; Gromke T; Hassel JC; Kee D; Ramelyte E; Shoushtari AN; Wei AZ; et al. (Nature medicine, 2026)